A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial - Concepedia

Concepedia

Publication | Closed Access

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

27

Citations

30

References

2018

Year

Cesar A. Santa‐Maria, Aditya Bardia, Amanda L. Blackford, Claire Snyder, Roisín M. Connolly, John H. Fetting, Daniel F. Hayes, Stacie C. Jeter, Robert S. Miller, Anne Nguyen,

Breast Cancer Research and Treatment

Zoledronic AcidChronic Musculoskeletal ConditionClinical TrialsOsteoarthritisPhase Ii StudyMusculoskeletal FunctionZap TrialMedicineOsteoporosisRheumatoid Arthritis

References

	Year	Citations

Page 1

Page 1